Repligen Corp at JPMorgan Healthcare Conference Transcript
Good morning, everyone. I'm Julia Qin. I work on life science tools and diagnostics team here at JPMorgan. And it is my great pleasure to introduce you to our next company presentation today, Repligen. As a reminder, after this session, there is a breakout in the Georgian Room. And with that, I would turn it over to Tony. Welcome.
Thanks, Julia. Welcome, everybody, and it's great to be here again this year. I just want to thank the JPMorgan team for giving us an opportunity to discuss not only the tremendous progress we made at Repligen in 2019, give you a little bit of insight to what we think is going to happen in 2020, and then talk a little bit about the next 5 years and what we view as the key part of our strategy as we continue to grow and take share in the bioprocessing market.
So I think everybody knows we're now one of the leading players in bioprocessing. If you actually
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
